menu
    • menu

    Company profile for TenNor Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    TenNor Therapeutics is a clinical stage company focusing on global development of differentiated products for the treatment of diseases caused by bacterial infection or dysbiosis. TenNor possesses a strong new drug development portfolio targeting medical device associated bacterial biofilm infections, cirrhosis hepatic encephalopathy and Helicobacter pylori infection, to address unmet medical needs in these areas.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TenNor TherapeuticsChina Flag
    Country
    Country
    China
    Address
    Address
    218 Xinghu Street, Building B2, Suite 711, Suzhau Industrial Park, China 21512...
    Telephone
    Telephone
    8651286861990
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.tennorx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TenNor Announces Positive Results from Rifasutenizol Phase III
    TenNor Announces Positive Results from Rifasutenizol Phase III

    18 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tennor-announces-positive-topline-results-from-rifasutenizol-phase-iii-trial-for-h-pylori-infection-302306898.html

    PR NEWSWIRE
    18 Nov 2024
    Share Share
    TenNor Secures 300 Million RMB Financing For Late-Stage Assets
    TenNor Secures 300 Million RMB Financing For Late-Stage Assets

    16 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/tennor-announces-more-than-300-million-rmb-financing-to-support-development-and-commercialization-of-late-stage-assets-including-rifasutenizol-for-heliobacter-pylori-infections-302275043.html

    PR NEWSWIRE
    16 Oct 2024
    Share Share
    TenNor Reports Positive Results of TNP-2092 Capsule for Liver Cirrhosis
    TenNor Reports Positive Results of TNP-2092 Capsule for Liver Cirrhosis

    22 Nov 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/tennor-reports-positive-results-of-tnp-2092-capsule-for-the-treatment-of-liver-cirrhosis-hyperammonemia-301429016.html

    PRNEWSWIRE
    22 Nov 2021
    Share Share
    TenNor Enters Research Collaboration with Janssen for Potential
    TenNor Enters Research Collaboration with Janssen for Potential

    20 Jan 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/tennor-enters-research-collaboration-with-janssen-for-potential-new-treatments-for-nontuberculous-mycobacteria-diseases-301209716.html

    PRNEWSWIRE
    20 Jan 2021
    Share Share
    TenNor Enters Research Collaboration with Janssen for Potential New Treatments
    TenNor Enters Research Collaboration with Janssen for Potential New Treatments

    18 Jan 2021

    // PRNASIA

    https://en.prnasia.com/releases/global/tennor-enters-research-collaboration-with-janssen-for-potential-new-treatments-for-nontuberculous-mycobacteria-diseases-305994.shtml

    PRNASIA
    18 Jan 2021
    Share Share
    TenNor inks research pact with Janssen for potential new treatments
    TenNor inks research pact with Janssen for potential new treatments

    18 Jan 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=134884&sid=2

    PHARMABIZ
    18 Jan 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search